| 1 |
31954879 | β-Lactams with antiproliferative and antiapoptotic activity in breast and chemoresistant colon cancer cells. | 2020 Mar 1 |
8 |
| 2 |
29306206 | Design, synthesis, biological evaluation and cocrystal structures with tubulin of chiral β-lactam bridged combretastatin A-4 analogues as potent antitumor agents. | 2018 Jan 20 |
2 |
| 3 |
28254699 | β-Lactam analogues of combretastatin A-4 prevent metabolic inactivation by glucuronidation in chemoresistant HT-29 colon cancer cells. | 2017 Apr 21 |
2 |
| 4 |
26845138 | Synthesis of Combretastatin A-4 Analogs and their Biological Activities. | 2016 |
1 |
| 5 |
27805821 | Potent Antitumor Activities and Structure Basis of the Chiral β-Lactam Bridged Analogue of Combretastatin A-4 Binding to Tubulin. | 2016 Nov 23 |
2 |
| 6 |
23232969 | Novel cis-restricted β-lactam combretastatin A-4 analogues display anti-vascular and anti-metastatic properties in vitro. | 2013 Feb |
1 |
| 7 |
23564200 | Combretazet-3 a novel synthetic cis-stable combretastatin A-4-azetidinone hybrid with enhanced stability and therapeutic efficacy in colon cancer. | 2013 Jun |
3 |
| 8 |
20699436 | The vascular targeting agent combretastatin-A4 and a novel cis-Restricted {beta}-Lactam Analogue, CA-432, induce apoptosis in human chronic myeloid leukemia cells and ex vivo patient samples including those displaying multidrug resistance. | 2010 Nov |
4 |